Quantitative evaluation of the genus Bifidobacterium in stool samples of patients with type 1 and 2 diabetes

[1] Xu M, Wang B, Fu Y, Chen Y, Yang F, Lu H, Li L. Changes of fecal Bifidobacterium species in adult patients with Hepatitis B virus-induced chronic liver disease. Microb Ecol. 2012; 63: 304–313. XuM WangB FuY ChenY YangF LuH LiL Changes of fecal Bifidobacterium species in adult patients with Hepatitis B virus-induced chronic liver disease Microb Ecol 2012 63 304 313 Search in Google Scholar

[2] Maukonen J, Kolho KJ, Paasela M, Honkanen J, Klemetti P, Vaarala O, Saarela M. Altered fecal mikrobiota in paediatric inflammatory bowel disease. J Crohns Colitis. 2015; 9: 1088–1095. MaukonenJ KolhoKJ PaaselaM HonkanenJ KlemettiP VaaralaO SaarelaM Altered fecal mikrobiota in paediatric inflammatory bowel disease J Crohns Colitis 2015 9 1088 1095 Search in Google Scholar

[3] Kerckhoffs AP, Samsom M, van der Rest ME, de Vogel J, Knol J, Ben-Amor K, Akkermans LM. Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol. 2009; 15: 2887–2892. KerckhoffsAP SamsomM van der RestME de VogelJ KnolJ Ben-AmorK AkkermansLM Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients World J Gastroenterol 2009 15 2887 2892 Search in Google Scholar

[4] Golfetto L, de Senna FD, Hermes J, Beserra BT, França FD, Martinello F. Lower Bifidobacteria counts in adult patients with celiac disease on a gluten-free diet. Arq. Gastroenterol. 2014; 51: 139–143. GolfettoL de SennaFD HermesJ BeserraBT FrançaFD MartinelloF Lower Bifidobacteria counts in adult patients with celiac disease on a gluten-free diet Arq. Gastroenterol. 2014 51 139 143 Search in Google Scholar

[5] De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Francavilla R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE. 2013; 8: e76993. De AngelisM PiccoloM VanniniL SiragusaS De GiacomoA SerrazzanettiDI FrancavillaR Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified PLoS ONE 2013 8 e76993 Search in Google Scholar

[6] Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020; 123: 1127–1137. AmabebeE RobertFO AgbalalahT OrubuESF Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism Br J Nutr 2020 123 1127 1137 Search in Google Scholar

[7] Tojo R. Intestinal microbiota in health and disease Role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 2014; 20: 15163. TojoR Intestinal microbiota in health and disease Role of bifidobacteria in gut homeostasis World J. Gastroenterol. 2014 20 15163 Search in Google Scholar

[8] Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance BA, Verchere CB, van Raalte DH, Herrema H. Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Front Immunol. 2020; 16: 571731. ScheithauerTPM RampanelliE NieuwdorpM VallanceBA VerchereCB van RaalteDH HerremaH Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes Front Immunol 2020 16 571731 Search in Google Scholar

[9] Gosiewski T, Salamon D, Szopa M, Sroka A, Malecki MT, Bulanda M. Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - A pilot study. Gut Pathog. 2014; 6: 43. GosiewskiT SalamonD SzopaM SrokaA MaleckiMT BulandaM Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes - A pilot study Gut Pathog 2014 6 43 Search in Google Scholar

[10] Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N. Role of gut microbiota in type 2 diabetes pathophysiology. eBioMedicine. 2020; 51: 496. GurungM LiZ YouH RodriguesR JumpDB MorgunA ShulzhenkoN Role of gut microbiota in type 2 diabetes pathophysiology eBioMedicine 2020 51 496 Search in Google Scholar

[11] Krawczyk A, Salamon D, Kowalska-Duplaga K, Bogiel T, Gosiewski T. Association of fungi and archaea of the gut microbiota with Crohn’s disease in pediatric patients-pilot study. Pathogens. 2021; 10: 1119. KrawczykA SalamonD Kowalska-DuplagaK BogielT GosiewskiT Association of fungi and archaea of the gut microbiota with Crohn’s disease in pediatric patients-pilot study Pathogens 2021 10 1119 Search in Google Scholar

[12] Salamon D, Gosiewski T, Krawczyk A, Sroka-Oleksiak A, Duplaga M, Fyderek K, Kowalska-Duplaga K. Quantitative changes in selected bacteria in the stool during the treatment of Crohn’s disease. Adv. Med. Sci. 2020; 65: 348–353. SalamonD GosiewskiT KrawczykA Sroka-OleksiakA DuplagaM FyderekK Kowalska-DuplagaK Quantitative changes in selected bacteria in the stool during the treatment of Crohn’s disease Adv. Med. Sci. 2020 65 348 353 Search in Google Scholar

[13] Matsuki T, Watanabe K, Fujimoto J, Takada T, Matsumoto K, Kado Y. Quantitative PCR with 16S primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol. 2004; 70:167–173. MatsukiT WatanabeK FujimotoJ TakadaT MatsumotoK KadoY Quantitative PCR with 16S primers for analysis of human intestinal bifidobacteria Appl. Environ. Microbiol. 2004 70 167 173 Search in Google Scholar

[14] Sinclair L, Osman OA, Bertilsson S, Eiler A. Microbial community composition and diversity via 16S rRNA gene amplicons: Evaluating the illumina platform. PLoS ONE. 2015; 10: e0116955. SinclairL OsmanOA BertilssonS EilerA Microbial community composition and diversity via 16S rRNA gene amplicons: Evaluating the illumina platform PLoS ONE 2015 10 e0116955 Search in Google Scholar

[15] Le KA, Li Y, Xu X, Yang W, Liu T, Zhao X, Hui H. Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population. Front. Physiol. 2013;3: 496. LeKA LiY XuX YangW LiuT ZhaoX HuiH Alterations in fecal Lactobacillus and Bifidobacterium species in type 2 diabetic patients in Southern China population Front. Physiol. 2013 3 496 Search in Google Scholar

[16] Wu X, Ma C, Han L, Nawaz M, Gao F, Zhang X, Yu P, Zhao C, Li L, Zhou A, et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol. 2010; 61: 69–78. WuX MaC HanL NawazM GaoF ZhangX YuP ZhaoC LiL ZhouA Molecular characterisation of the faecal microbiota in patients with type II diabetes Curr Microbiol 2010 61 69 78 Search in Google Scholar

[17] Shillitoe E, Weinstock R, Kim T, Simon H, Planer J, Noonan S, Cooney R. The oral microflora in obesity and type-2 diabetes. J. Oral Microbiol. 2012; 4: 19013. ShillitoeE WeinstockR KimT SimonH PlanerJ NoonanS CooneyR The oral microflora in obesity and type-2 diabetes J. Oral Microbiol 2012 4 19013 Search in Google Scholar

[18] Allin KH, Nielsen T, Pedersen O. Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol. 2015; 172: 167–177. AllinKH NielsenT PedersenO Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus Eur J Endocrinol 2015 172 167 177 Search in Google Scholar

[19] Baothman OA, Zamzami MA, Taher I, Abubaker J, Abu-Farha M. The role of gut microbiota in the development of obesity and diabetes. Lipids Health Dis. 2016; 15: 108. BaothmanOA ZamzamiMA TaherI AbubakerJ Abu-FarhaM The role of gut microbiota in the development of obesity and diabetes Lipids Health Dis 2016 15 108 Search in Google Scholar

[20] Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004; 25: 4–7. DandonaP AljadaA BandyopadhyayA Inflammation: the link between insulin resistance, obesity and diabetes Trends Immunol 2004 25 4 7 Search in Google Scholar

[21] Murri M, Leiva I, Gomez-Zumaquero JM, Tinahones FJ, Cardona F, Soriguer F, Queipo-Ortuño MI. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 2013; 11: 46. MurriM LeivaI Gomez-ZumaqueroJM TinahonesFJ CardonaF SoriguerF Queipo-OrtuñoMI Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study BMC Med 2013 11 46 Search in Google Scholar

[22] Wang J, Qin J, Li Y, Cai Z, Li S, Zhu J, Wang J. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012; 490: 55–60. WangJ QinJ LiY CaiZ LiS ZhuJ WangJ A metagenome-wide association study of gut microbiota in type 2 diabetes Nature 2012 490 55 60 Search in Google Scholar

[23] De Goffau MC, Fuentes S, van den Bogert B, Honkanen H, de Vos WM, Welling GW, Hyöty H, Harmsen HJ. Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetologia. 2014; 57: 1569–1577. De GoffauMC FuentesS van den BogertB HonkanenH de VosWM WellingGW HyötyH HarmsenHJ Aberrant gut microbiota composition at the onset of type 1 diabetes in young children Diabetologia 2014 57 1569 1577 Search in Google Scholar

[24] Soyucen E, Gulcan A, Aktuglu-Zeybek AC, Onal H, Kiykim E, Aydin A. Differences in the gut microbiota of healthy children and those with type 1 diabetes. Pediatrics International., 2014; 56: 336–343. SoyucenE GulcanA Aktuglu-ZeybekAC OnalH KiykimE AydinA Differences in the gut microbiota of healthy children and those with type 1 diabetes Pediatrics International 2014 56 336 343 Search in Google Scholar

[25] Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr. 2009; 101: 541–50. Ramirez-FariasC SlezakK FullerZ DuncanA HoltropG LouisP Effect of inulin on the human gut microbiota: Stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii Br J Nutr 2009 101 541 50 Search in Google Scholar

[26] Moreno-Indias I, Cardona F, Tinahones FJ, Queipo-Ortuño MI. Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol. 2014; 5: 190. Moreno-IndiasI CardonaF TinahonesFJ Queipo-OrtuñoMI Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus Front Microbiol 2014 5 190 Search in Google Scholar

[27] Wang G, Si Q, Yang S, Jiao T, Zhu H, Tian P, Wang L, Li X, Gong L, Zhao J, et al. Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners. Food Funct. 2020; 11: 5898–5914. WangG SiQ YangS JiaoT ZhuH TianP WangL LiX GongL ZhaoJ Lactic acid bacteria reduce diabetes symptoms in mice by alleviating gut microbiota dysbiosis and inflammation in different manners Food Funct 2020 11 5898 5914 Search in Google Scholar

[28] Akbari V, Hendijani F. Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutr Rev. 2016; 74: 774–784. AkbariV HendijaniF Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis Nutr Rev 2016 74 774 784 Search in Google Scholar

[29] Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006; 444: 1022–1023. LeyRE TurnbaughPJ KleinS GordonJI Microbial ecology: human gut microbes associated with obesity Nature 2006 444 1022 1023 Search in Google Scholar

[30] Marlicz W, Ostrowska L, Łoniewski I. Intestinal microbiota and its potential relationship with obesity. Endokrynol Otył Zab Przem Mat. 2013; 9: 20–28. MarliczW OstrowskaL ŁoniewskiI Intestinal microbiota and its potential relationship with obesity Endokrynol Otył Zab Przem Mat 2013 9 20 28 Search in Google Scholar

[31] Gong H, Gao H, Ren Q, He J. The abundance of bifidobacterium in relation to visceral obesity and serum uric acid. Sci Rep. 2022; 12: 13073. GongH GaoH RenQ HeJ The abundance of bifidobacterium in relation to visceral obesity and serum uric acid Sci Rep 2022 12 13073 Search in Google Scholar

[32] Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004; 101: 15718–15723. BäckhedF DingH WangT HooperLV KohGY NagyA SemenkovichCF GordonJI The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci USA 2004 101 15718 15723 Search in Google Scholar

[33] Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Hostbacterial mutualism in the human intestine. Science. 2005; 307: 1915–1920. BäckhedF LeyRE SonnenburgJL PetersonDA GordonJI Hostbacterial mutualism in the human intestine Science 2005 307 1915 1920 Search in Google Scholar

[34] Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006; 444: 1027–1031.Table 2 TurnbaughPJ LeyRE MahowaldMA MagriniV MardisER GordonJI An obesity-associated gut microbiome with increased capacity for energy harvest Nature 2006 444 1027 1031 Table 2 Search in Google Scholar